Cherry Hill: Daughter’s opioid death caused by ‘corporate greed’

As Seen In:

GET A FREE CONSULTATION

PRACTICE AREAS

RECENT RESULTS

U.S. Sen. Claire McCaskill (D., Mo.) took aim during a hearing Tuesday at marketing practices by the pharmaceutical industry generally and the behavior of one company in particular: Insys Therapeutics Inc., which made the powerful opioid believed to have played a role in the death of 32-year-old Sarah Fuller in Camden County last year.

Her mother, Deborah, described listening to an audio recording in which a drug company representative falsely said she was from Sarah’s doctor’s office and misled a pharmacy benefits manager into believing that Sarah had breakthrough cancer pain. That’s the only condition that Insys’ fast-acting fentanyl brand, Subsys, was approved to treat.

Read the full story on Philly.com

    Ready for a no-cost consultation?

    Speak directly to Richard Hollawell today - there is never a fee until we win your case.

    You have Successfully Subscribed!